Showing results (311-320 of 410) with videos related to

Sort By:
Pageof 41
European Heart Journal. Quality of Care & Clinical Outcomes|September 24, 2021
The PRECISE-DAPT score and 5-year outcomes after percutaneous coronary intervention: a large-scale, real-world study from ChinaXueyan Zhao, Jiawen Li, Fangchao Liu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 20, 2024
Efficacy and safety of yangxinshi versus trimetazidine on exercise tolerance in patients with coronary heart disease after percutaneous coronary intervention: Multicenter, double-blind clinical trialYang Li, Yi Li, Zhijie Zhang, et al.
Frontiers in Cardiovascular Medicine|October 31, 2022
Neutrophil infiltration and myocarditis in patients with severe COVID-19: A post-mortem studyQuanyu Zhang, Huarong Zhang, Xiaowei Yan, et al.
Journal of the American Heart Association|September 18, 2024
In-Hospital Mortality and Treatment in Patients With Acute Coronary Syndrome With and Without Standard Modifiable Cardiovascular Risk Factors: Findings From the CCC-ACS ProjectWei Gong, Yan Yan, Jing Liu, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 29, 2016
Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trialHeyang Wang, Yi Li, Hongliang Cong, et al.
Cardiovascular Therapeutics|January 14, 2017
Effect of postprocedural full-dose infusion of bivalirudin on acute stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Outcomes in a large real-world populationHeyang Wang, Zhenyang Liang, Yi Li, et al.
International Journal of Cardiology|November 13, 2020
Long-term antiplatelet therapy in medically managed non-ST-segment elevation acute coronary syndromes: The EPICOR Asia studyJuan Zhou, Chee Tang Chin, Xin Huang, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 4, 2021
Long-Term Antithrombotic Therapy and Clinical Outcomes in Patients with Acute Coronary Syndrome and Renal Impairment: Insights from EPICOR and EPICOR AsiaYong Huo, Frans Van de Werf, Yaling Han, et al.
Cardiovascular Drugs and Therapy|March 1, 2018
Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU StudyRunlin Gao, Yongjian Wu, Hengliang Liu, et al.
Frontiers in Cardiovascular Medicine|May 2, 2022
Association Between Early Oral β-Blocker Therapy and In-Hospital Outcomes in Patients With ST-Elevation Myocardial Infarction With Mild-Moderate Heart Failure: Findings From the CCC-ACS ProjectMiao Wang, Jing Liu, Jun Liu, et al.
Pageof 41